Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anal Canal Carcinoma
×
pembrolizumab
×
Clear all
Filters
2
NCT06640283
2025-12-24
ANA
Instituto do Cancer do Estado de São Paulo
Phase 2
Recruiting
150 enrolled